• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒重组和替代性端粒延长机制。

Telomere recombination and alternative telomere lengthening mechanisms.

机构信息

Institut Curie, Centre de recherche, 75005 Paris, France.

出版信息

Front Biosci (Landmark Ed). 2013 Jan 1;18(1):1-20. doi: 10.2741/4084.

DOI:10.2741/4084
PMID:23276906
Abstract

Telomeres are nucleoprotein structures at the ends of linear chromosomes that protect them from being recognized as DNA double stranded breaks. Telomeres shorten with every cell division and in the absence of the checkpoint mechanisms critical telomere shortening leads to chromosome end fusions and genomic instability. Cancer cells achieve immortality by engaging in one of the two known mechanisms for telomere maintenance: elongation by telomerase or through recombination. Recombination based elongation of telomeres, also known as alternative lengthening of telomeres or ALT, is prevalent among cancers of mesenchymal origin. However, the conditions favoring ALT emergence are not known. Here we will discuss possible players in ALT mechanisms, including recruitment of telomeres to recombination centers, alterations of telomere associated proteins and modifications at the level of chromatin that could generate recombination permissive conditions at telomeres.

摘要

端粒是线性染色体末端的核蛋白结构,可防止它们被识别为 DNA 双链断裂。随着每个细胞分裂,端粒会缩短,而没有关键的检查点机制,端粒的缩短会导致染色体末端融合和基因组不稳定。癌细胞通过两种已知的端粒维持机制之一实现永生:端粒酶延长或通过重组。端粒的重组延长,也称为端粒的替代性延长或 ALT,在间充质来源的癌症中很常见。然而,促进 ALT 出现的条件尚不清楚。在这里,我们将讨论 ALT 机制中的可能参与者,包括端粒向重组中心的募集、端粒相关蛋白的改变以及染色质水平的修饰,这些都可以在端粒处产生有利于重组的条件。

相似文献

1
Telomere recombination and alternative telomere lengthening mechanisms.端粒重组和替代性端粒延长机制。
Front Biosci (Landmark Ed). 2013 Jan 1;18(1):1-20. doi: 10.2741/4084.
2
WRN loss induces switching of telomerase-independent mechanisms of telomere elongation.WRN缺失诱导端粒酶非依赖性端粒延长机制的转换。
PLoS One. 2014 Apr 7;9(4):e93991. doi: 10.1371/journal.pone.0093991. eCollection 2014.
3
Telomere dysfunction and genome instability.端粒功能障碍与基因组不稳定。
Front Biosci (Landmark Ed). 2012 Jun 1;17(6):2181-96. doi: 10.2741/4044.
4
Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT-associated proteins.端粒悬突长度决定了结构动力学以及端粒酶和端粒酶替代途径(ALT)相关蛋白的可及性。
Structure. 2014 Jun 10;22(6):842-53. doi: 10.1016/j.str.2014.03.013. Epub 2014 May 15.
5
Human RECQL1 participates in telomere maintenance.人类 RECQL1 参与端粒维持。
Nucleic Acids Res. 2014 May;42(9):5671-88. doi: 10.1093/nar/gku200. Epub 2014 Mar 12.
6
The Altered Functions of Shelterin Components in ALT Cells.端粒酶相关细胞中庇护体蛋白的功能改变。
Int J Mol Sci. 2023 Nov 27;24(23):16830. doi: 10.3390/ijms242316830.
7
Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.没有端粒酶的生命与癌症:替代延长端粒途径(ALT)及确保染色体末端(不)融合的其他策略
Crit Rev Biochem Mol Biol. 2017 Feb;52(1):57-73. doi: 10.1080/10409238.2016.1260090. Epub 2016 Nov 28.
8
How long does telomerase extend telomeres? Regulation of telomerase release and telomere length homeostasis.端粒酶能延长端粒多长时间?端粒酶释放的调控与端粒长度稳态。
Curr Genet. 2018 Dec;64(6):1177-1181. doi: 10.1007/s00294-018-0836-6. Epub 2018 Apr 16.
9
SMARCAL1 Resolves Replication Stress at ALT Telomeres.SMARCAL1可解决端粒延长(ALT)型端粒处的复制应激问题。
Cell Rep. 2016 Feb 9;14(5):1032-1040. doi: 10.1016/j.celrep.2016.01.011. Epub 2016 Jan 28.
10
The makings of TERRA R-loops at chromosome ends.端粒处的 TERRA R-环的构成。
Cell Cycle. 2021 Sep;20(18):1745-1759. doi: 10.1080/15384101.2021.1962638. Epub 2021 Aug 25.

引用本文的文献

1
Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer.基于碳基量子点的肿瘤诊断:基于癌症特征的检测
Bioact Mater. 2023 Nov 15;33:174-222. doi: 10.1016/j.bioactmat.2023.10.004. eCollection 2024 Mar.
2
Investigating the origin of subtelomeric and centromeric AT-rich elements in Aspergillus flavus.研究黄曲霉端粒和着丝粒富含 AT 序列的起源。
PLoS One. 2023 Feb 9;18(2):e0279148. doi: 10.1371/journal.pone.0279148. eCollection 2023.
3
The epigenetic regulation of centromeres and telomeres in plants and animals.
植物和动物中着丝粒与端粒的表观遗传调控。
Comp Cytogenet. 2020 Jul 7;14(2):265-311. doi: 10.3897/CompCytogen.v14i2.51895. eCollection 2020.
4
G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.四链体稳定促进 ALT 阳性骨肉瘤细胞中的 ALT 通路。
Genes (Basel). 2020 Mar 13;11(3):304. doi: 10.3390/genes11030304.
5
SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability.SFPQ 和 NONO 抑制 RNA:DNA 杂交相关的端粒不稳定。
Nat Commun. 2019 Mar 1;10(1):1001. doi: 10.1038/s41467-019-08863-1.
6
Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).端粒长度在癌症中的维持:端粒酶与端粒的非酶延长(ALT)的十字路口。
Int J Mol Sci. 2018 Feb 18;19(2):606. doi: 10.3390/ijms19020606.
7
RAD51 and RTEL1 compensate telomere loss in the absence of telomerase.RAD51 和 RTEL1 补偿端粒酶缺失导致的端粒丢失。
Nucleic Acids Res. 2018 Mar 16;46(5):2432-2445. doi: 10.1093/nar/gkx1322.
8
Differential requirements for DNA repair proteins in immortalized cell lines using alternative lengthening of telomere mechanisms.使用端粒延长替代机制的永生化细胞系中DNA修复蛋白的差异需求。
Genes Chromosomes Cancer. 2017 Aug;56(8):617-631. doi: 10.1002/gcc.22465. Epub 2017 May 31.
9
Transient ALT activation protects human primary cells from chromosome instability induced by low chronic oxidative stress.短暂的 ALT 激活可保护人原代细胞免受低慢性氧化应激诱导的染色体不稳定性。
Sci Rep. 2017 Feb 27;7:43309. doi: 10.1038/srep43309.
10
Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.端粒的替代延长可通过滞后链的优先延长来维持。
Nucleic Acids Res. 2017 Mar 17;45(5):2615-2628. doi: 10.1093/nar/gkw1295.